Search results for query: *

  1. DoNotGoGentle

    Otonomy OTO-311 Phase II Clinical Trial for Tinnitus

    Thank you for your inquiry regarding Otonomy’s clinical trials for our tinnitus product candidate, OTO-311. The FDA has cleared the company's Investigational New Drug application (IND) for OTO-311. The IND clearance enables Otonomy to initiate a Phase 1 dose escalation clinical safety trial of...